Items Per Page 102550 Year All2024202320222021202020192018201720162015201420132012201120102009 May 6, 2024 Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT PDF Version May 3, 2024 Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version April 4, 2024 Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PDF Version March 26, 2024 Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update PDF Version March 20, 2024 Delcath Systems Closes $7 Million Private Placement PDF Version March 19, 2024 Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call PDF Version March 18, 2024 Delcath Systems Appoints Martha S. Rook as Chief Operating Officer PDF Version March 15, 2024 Delcath Systems Announces $7 Million Private Placement PDF Version March 8, 2024 Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version March 8, 2024 Delcath Systems to Participate in Upcoming Investor Conferences PDF Version
May 6, 2024 Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT PDF Version
May 3, 2024 Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version
March 26, 2024 Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update PDF Version
March 19, 2024 Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call PDF Version
March 8, 2024 Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version
